Followers | 180 |
Posts | 9142 |
Boards Moderated | 4 |
Alias Born | 08/16/2010 |
Monday, July 28, 2014 9:13:57 PM
The target price for Greenlight Reinsurance is set to $40.
Greenlight Reinsurance shares have surged 29.81% over the past 52 weeks, while the S&P 500 index has gained 17.39% in the same period.
Greenlight Reinsurance's shares dropped 1.00% to close at $33.57 on Friday.
L
http://m.benzinga.com/article/4733402
Recent GLRE News
- Greenlight Capital Re, Ltd. Schedules First Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 05/02/2024 08:25:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:30:29 PM
- Greenlight Re Announces Fourth Quarter and Year-end 2023 Financial Results • GlobeNewswire Inc. • 03/05/2024 09:15:00 PM
- Greenlight Capital Re, Ltd. Schedules Fourth Quarter and Year-End 2023 Financial Results and Conference Call • GlobeNewswire Inc. • 02/27/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 12:33:58 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 11:42:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:33:55 PM
- AM Best Comments on Credit Ratings of Greenlight Capital Re, Ltd. and Subsidiaries Following Announced Departure of CEO Simon Burton • Business Wire • 11/10/2023 02:50:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:45:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:22:00 PM
- Greenlight Re Announces Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/08/2023 09:15:00 PM
- Greenlight Capital Re, Ltd. Announces New Chief Executive Officer • GlobeNewswire Inc. • 11/07/2023 09:15:00 PM
- Greenlight Capital Re, Ltd. Schedules Third Quarter 2023 Financial Results And Conference Call • GlobeNewswire Inc. • 11/01/2023 12:35:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 07:59:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 07:57:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 07:54:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 07:50:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 07:48:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 07:45:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 09:29:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/02/2023 09:13:28 PM
- Greenlight Re Announces Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/02/2023 08:15:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/31/2023 08:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/27/2023 08:25:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/03/2023 07:02:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM